Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023
Mon, December 18, 2023
Fri, December 15, 2023
Thu, December 14, 2023

Leland Gershell Maintained (VRDN) at Buy with Increased Target to $36 on, Dec 19th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-36-on-dec-19th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Increased Target from $35 to $36 on, Dec 19th, 2023.

Leland has made no other calls on VRDN in the last 4 months.



There are 6 other peers that have a rating on VRDN. Out of the 6 peers that are also analyzing VRDN, 0 agree with Leland's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Leland


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $37 on, Monday, December 18th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $37 on, Monday, December 4th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 14th, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Monday, October 30th, 2023
  • Alex Thompson of "Stifel" Reiterated at Strong Buy and Held Target at $40 on, Wednesday, September 13th, 2023

Publication Contributing Sources